Kidney ccRCC immune classification (KIC) enhances the predictive value of T effector (Teff) and angiogenesis (Angio) signatures in response to nivolumab (N) - Université d'Angers Accéder directement au contenu
Article Dans Une Revue Annals of Oncology Année : 2020

Kidney ccRCC immune classification (KIC) enhances the predictive value of T effector (Teff) and angiogenesis (Angio) signatures in response to nivolumab (N)

M. Gross-Goupil
  • Fonction : Auteur

Dates et versions

hal-03040225 , version 1 (04-12-2020)

Identifiants

Citer

M. Meylan, B Beuselinck, C. Dalban, Y. Vano, N. Rioux Leclercq, et al.. Kidney ccRCC immune classification (KIC) enhances the predictive value of T effector (Teff) and angiogenesis (Angio) signatures in response to nivolumab (N). Annals of Oncology, 2020, 31, pp.S553-S553. ⟨10.1016/j.annonc.2020.08.772⟩. ⟨hal-03040225⟩
31 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More